| # | Drug | Count |
|---|---|---|
| 0 | PREDNISONE | 38 |
| 1 | CYCLOPHOSPHAMIDE | 35 |
| 2 | CYCLOPHOSPHAMIDE FOR INJECTION | 35 |
| 3 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 35 |
| 4 | ASPIRIN | 34 |
| 5 | ASPIRIN 325 MG | 34 |
| 6 | ASPIRIN 81 MG | 34 |
| 7 | ERGOCALCIFEROL | 32 |
| 8 | CIPROFLOXACIN HYDROCHLORIDE | 31 |
| 9 | FLUDARABINE PHOSPHATE | 28 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | CIDOFOVIR ANHYDROUS | 14 | 0.0097 |
| 1 | PIFLUFOLASTAT F-18 | 2 | 0.0060 |
| 2 | CASTOR OIL | 1 | 0.0052 |
| 3 | FOSCARNET SODIUM | 14 | 0.0035 |
| 4 | IBANDRONATE SODIUM | 9 | 0.0029 |
| 5 | KETAMINE HYDROCHLORIDE | 12 | 0.0023 |
| 6 | CROTAMITON | 1 | 0.0016 |
| 7 | CABAZITAXEL | 5 | 0.0014 |
| 8 | CROMOLYN SODIUM | 5 | 0.0014 |
| 9 | CUPRIC CHLORIDE | 1 | 0.0013 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 66 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 54 |
| 2 | Kinase Inhibitor [EPC] | 44 |
| 3 | Alkylating Drug [EPC] | 36 |
| 4 | Benzodiazepine [EPC] | 36 |
| 5 | Angiotensin 2 Receptor Blocker [EPC] | 35 |
| 6 | Platelet Aggregation Inhibitor [EPC] | 34 |
| 7 | Provitamin D2 Compound [EPC] | 32 |
| 8 | CD20-directed Cytolytic Antibody [EPC] | 31 |
| 9 | HMG-CoA Reductase Inhibitor [EPC] | 31 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Provitamin D2 Compound [EPC] | 32 | 0.0011 |
| 1 | Guanylate Cyclase-C Agonist [EPC] | 2 | 0.0010 |
| 2 | Human Immunoglobulin G [EPC] | 17 | 0.0008 |
| 3 | Radioactive Diagnostic Agent [EPC] | 2 | 0.0006 |
| 4 | Selective T Cell Costimulation Blocker [EPC] | 3 | 0.0006 |
| 5 | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 14 | 0.0006 |
| 6 | Type I Interferon Receptor Antagonist [EPC] | 1 | 0.0005 |
| 7 | Plasma Kallikrein Inhibitor [EPC] | 1 | 0.0004 |
| 8 | Lipid-based Polyene Antifungal [EPC] | 5 | 0.0004 |
| 9 | Estrogen Receptor Antagonist [EPC] | 14 | 0.0003 |